Today’s M & A Deals_March 31,2016

M &  A Deals :

 

 

Today’s Wealth Mantra !

“You get recessions, you have stock market declines. If you don’t understand that’s going to happen, then you’re not ready, you won’t do well in the markets.

― Peter Lynch

 

current scheme

Current IPO_HCG_Healthcare Global Enterprises Limited

Healthcare Global Enterprises Ltd.
Issue Open Date 16-Mar-16
Issue Closing Date 18-Mar-16
Application Money 100
Allotment Money
Price Band (Rs.) 205 – 218
Minimum Bid Quantity. 65
Issue Size (Shares) 29800000
Market Lot 1

 

Objectives :

  1. Purchase of medical equipment
  2. Investment in IT software, services and hardware
  3. Pre-payment of debt
  4. General corporate purposes

Business Description :

Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in India focused on cancer and fertility.

HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. HCG also operates fertility centres under the ‘Milann’ brand.

As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centres, including centre of excellence in Bengaluru, three freestanding diagnostic centres and one day care chemotherapy centre across India.

HCG acquired 50.10% equity in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG now operate four Milann fertility centres in Bengaluru. BACC Healthcare is led by a team of qualified and experienced fertility specialists. Its founder, Dr. Kamini Rao has a successful track record of over 25 years of providing fertility treatments. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment.

Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialisation in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in centre of excellence in Bengaluru.

 

 

 

Company Financials:

Particulars For the year/period ended (in Rs. Million)
31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12 31-Mar-11
Total Liabilities 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Assets 6,895.42 6,138.21 6,436.40 4,362.63 3,203.63
Total Revenue 4,244.41 3,525.94 2,939.52 2,051.67 1,601.43
Profit After Tax (PAT) (23.66) (394.98) (71.58) (40.02) 34.40

 

Healthcare Global IPO Lead Manager(s)

1. Edelweiss Capital Limited

2. Goldman Sachs (India) Securities Private Limited

3. IDFC Securities Limited

4. India Infoline Limited

5. Kotak Mahindra Capital Company Limited

6. YES Bank Limited

For further details & apply online